2021
DOI: 10.1097/md.0000000000025173 View full text |Buy / Rent full text
|
|

Abstract: Rationale: Bacterial and fungal infections in Coronavirus Disease-19 (COVID-19) patients have been inadequately investigated and reported thus far. The safety profile of tocilizumab (TCZ) administration in candidemia patient still debatable. Patient concerns: A 54 year-old woman presenting with weakness on the left side of her body was diagnosed with COVID-19. After 7 days of admission, her condition worsened and developed respiratory distress and was having respiratory… Show more

Help me understand this report

Search citation statements

Order By: Relevance
Select...
0
14
0

Publication Types

Select...

Relationship

0
0

Authors

Journals